CCR4 is also consistently expressed on the surface of tumor cells in T-cell malignancies, such as CTCL, including MF and SS, adult T-cell leukemia-lymphoma, and peripheral T-cell lymphoma (PTCL) (30–33). Here, CCR4 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.